Cargando…
The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin
BACKGROUND: Mannose-binding lectin (MBL) is an important component of innate immunity because it promotes bacterial clearance and neutralization of human influenza A viruses. Since a majority of humans have no neutralizing antibody against the pandemic (H1N1) 2009 influenza (pandemic 2009) virus, in...
Autores principales: | Tokunaga, Hirotoshi, Ushirogawa, Hiroshi, Ohuchi, Masanobu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045344/ https://www.ncbi.nlm.nih.gov/pubmed/21294904 http://dx.doi.org/10.1186/1743-422X-8-50 |
Ejemplares similares
-
Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic
por: Ushirogawa, Hiroshi, et al.
Publicado: (2016) -
No association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virus
por: Eisen, Damon P., et al.
Publicado: (2011) -
Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus
por: Ushirogawa, Hiroshi, et al.
Publicado: (2011) -
Mannose-Binding Lectin Contributes to Deleterious Inflammatory Response in Pandemic H1N1 and Avian H9N2 Infection
por: Ling, Man To, et al.
Publicado: (2012) -
Limited effect of recombinant human mannose-binding lectin on the infection of novel influenza A (H7N9) virus in vitro
por: Guo, Jinlei, et al.
Publicado: (2015)